The 2017 Vasculitis Symposium in Chicago will bring together some of the world's leading experts in autoimmune vasculitis. Patients and their families will also be coming to learn the latest medical and research news about vasculitis.
Duke University researchers have identified a potential new mechanism for Parkinson's disease in both mice and human endocrine cells that populate the small intestines.
Profs. Michal Schwartz and Ido Amit at the Weizmann Institute of Science have discovered a unique immune cell type whose regulated activation may form the foundation of a future treatment for Alzheimer’s disease
According to research reported online today in Neurology, the international Dementia with Lewy Bodies Consortium issued new guidelines about diagnosing and treating the disease and called for more clinical trials into the illness.
Penn researchers studying an inherited disorder of skin, hair follicles, nails, sweat glands, and teeth called hypohidrotic ectodermal dysplasia (HED) have identified a mechanism that may also be disrupted in male pattern baldness, a more common condition.
The milestone Imaging Dementia – Evidence for Amyloid Scanning (IDEAS) Study is working with government and academic researchers to launch three add-on studies to expand the impact of the core study where more than 18,000 people with cognitive decline but an unclear diagnosis will receive an amyloid PET scan.
For some patients, statins cause necrotizing myopathy, a form of the rare, chronic, debilitating condition idiopathic inflammatory myopathy, also known as myositis.
Cognitive tests can detect early Alzheimer’s disease in older adults without symptoms according to a new Keck School of Medicine of USC study.
World Thyroid Day Recognized Globally- May 25, 2017
The identification of 16 additional genetic markers will help researchers get closer to understanding how — and why — psoriasis develops.
A new DNA vaccine when delivered to the skin prompts an immune response that produces antibodies to protect against toxic proteins associated with Alzheimer’s disease – without triggering severe brain swelling that earlier antibody treatments caused in some patients.
Immune diseases like multiple sclerosis and hemophagocytic lymphohistiocytosis unleash destructive waves of inflammation on the body, causing death or a lifetime of illness and physical impairment. With safe and effective treatments in short supply, scientists report in PNAS Early Edition (Proceeding of the National Academy of Science) discovery of an experimental treatment that targets an Achilles heel of activated immune cells – killing them off and stopping autoimmune damage.
Superficially, psoriasis and atopic dermatitis may appear similar but their commonalities are only skin deep. Atopic dermatitis, also known as eczema, is primarily driven by an allergic reaction, while psoriasis is considered an autoimmune disease. Nevertheless, researchers at La Jolla Institute for Allergy and Immunology were able to pinpoint a common driver of skin inflammation in both diseases.
The grant will help fund a study to determine whether people with multiple sclerosis get as much benefit from an exercise-based rehabilitation program delivered via internet and telephone as they do when the therapy is provided in a clinic.
Faced with a serious disease, patients want to know the answer to a difficult question: “How long will I live?”
TMA-funded research fellow Xavier Suárez-Calvet, PhD is putting together pieces of the puzzle of dermatomyositis that may someday lead to more effective treatments for this rare autoimmune disease of the muscles.
The Vasculitis Foundation announces the launch of its month-long campaign to raise awareness about autoimmune vasculitis.
Graves' eye disease trial led by the University of Michigan Kellogg Eye Center shows success of 'breakthrough therapy" to reduce suffering and disfigurement.
Researchers at Sunnybrook Health Sciences Centre in Toronto have begun the world’s first clinical trial evaluating the feasibility and safety of opening the blood-brain barrier (BBB) in patients with Alzheimer’s disease (AD) utilizing focused ultrasound.
The lack of easily accessible, culturally proficient, and gerontology-trained providers creates a unique challenge for older adults in rural communities. Providing earlier cognitive assessment to facilitate earlier management of cognitive decline issues can assist with aging-in-place and decreased health care costs.
Francisco Goya is the most important Spanish artist of the 19th century. In 1793, Goya, then 46, came down with a severe, undiagnosed illness. His hearing never returned. Now, a hearing expert at the University of Maryland School of Medicine has developed a diagnosis.
May is Myositis Awareness Month, a time when The Myositis Association and its members spread the word about the challenges faced on a daily basis by the more than 50,000 Americans who live with myositis.
Celeste Lee, cherished wife, sister, daughter, mother, faithful friend, and passionate patient advocate, died at age 51 from the autoimmune disease vasculitis, surrounded by family and friends, both near and far. Celeste was a longtime member of the Vasculitis Foundation and a founding member of the North Carolina VF Support Group.
Spring fundraiser for AARDA evokes "Downton Abbey" era
Saint Louis University scientist Yuna Ayala, Ph.D., and her research team have made advances in understanding how damaging plaques build up in neurodegenerative illnesses like ALS and dementia.
Researchers in France have developed a new method that will allow doctors to detect minute amounts of a protein called interferon- in patient samples. The technique, which is described in the study “Detection of interferon- protein reveals differential levels and cellular sources in disease” published April 18 in The Journal of Experimental Medicine, will aid the diagnosis and treatment of numerous autoimmune diseases, including systemic lupus erythematosus (SLE) and dermatomyositis.
Unique graphic characters called Greebles may prove to be valuable tools in detecting signs of Alzheimer’s disease decades before symptoms become apparent.
A new study has found a link between neurological birth defects in infants commonly found in pregnant women with diabetes and several neurodegenerative diseases, including Alzheimer’s, Parkinson’s and Huntington’s diseases. This is the first time this link has been identified; it may indicate a new way to understand, and perhaps treat, both neural tube defects and these neurodegenerative diseases.
Infection with reovirus, a common but otherwise harmless virus, can trigger the immune system response to gluten that leads to celiac disease, according to new research from the University of Chicago and the University of Pittsburgh School of Medicine.
A Houston Methodist-led research team showed that the systemic administration of nanoparticles triggers an inflammatory response because of blood components accumulating on their surface.
The viruses hepatitis B and C may both be associated with an increased risk of Parkinson’s disease, according to a study published in the March 29, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology. The hepatitis virus affects the liver.
In experiments with a protein called Ephexin5 that appears to be elevated in the brain cells of Alzheimer's disease patients and mouse models of the disease, Johns Hopkins researchers say removing it prevents animals from developing Alzheimer's characteristic memory losses. In a report on the studies, published online March 27 in The Journal of Clinical Investigation, the researchers say the findings could eventually advance development of drugs that target Ephexin5 to prevent or treat symptoms of the disorder.
WASHINGTON, DC, MARCH 28, 2017 – With the intense focus of the Trump Administration and Republican leadership in Congress on repealing and replacing the Affordable Care Act (ACA) since the inauguration, a survey conducted by the American Autoimmune Related Diseases Association (AARDA) finds that the vast majority of autoimmune disease patients do not believe that U.S. elected officials, including President Trump as well as other Federal and State elected officials, understand that autoimmunity is a major U.S. health issue. In addition, they voice apprehension over the future of health insurance and what it means for their care, and believe that legislation must be in place to prevent insurance companies from taking medical decisions away from patients’ doctors.
Investigators at Rush University Medical Center and the Brigham and Women’s Hospital in Boston reported the discovery of a new gene that is associated with susceptibility to a common form of brain pathology called Tau that accumulates in several different conditions, including Alzheimer’s disease, certain forms of dementia and Parkinsonian syndromes as well as chronic traumatic encephalopathy that occurs with repeated head injuries.
The American Academy of Neurology is awarding two California researchers the 2017 Potamkin Prize for Research in Pick’s, Alzheimer’s and Related Diseases for their work in dementia research. Claudia Kawas, MD, of the University of California, Irvine, and Kristine Yaffe, MD, of the University of California, San Francisco, both members of the American Academy of Neurology, will be honored at the American Academy of Neurology’s 69th Annual Meeting in Boston.
Thin parts of the cell membranes of neurons turn out to be particularly vulnerable to a protein that collects in the brain of people with Alzheimer's disease, according to a University of Michigan researcher.
An international team of scientists, led by researchers at University of California San Diego School of Medicine and University of California San Francisco, has developed a novel genetic score that allows individuals to calculate their age-specific risk of developing Alzheimer’s disease (AD), based upon genetic information.
A study led by Assistant Professor Feng Lei from National University of Singapore’s Yong Loo Lin School of Medicine has found that regular consumption of tea lowers the risk of cognitive decline in the elderly, and this is especially so for APOE e4 gene carriers who are genetically at risk of developing Alzheimer’s disease.
Researchers at Beth Israel Deaconess Medical Center (BIDMC) have gained new insight into the genetic and neuronal circuit mechanisms that may contribute to impaired sociability in some forms of Autism Spectrum Disorder.
Singer and actress Selena Gomez made a donation to the Keck School of Medicine of University of Southern California (USC) to support lupus research. She created the fund, called the “Selena Gomez Fund for Lupus Research,” that will initially support a pilot research program focused on treating complications of lupus, led by Janos Peti-Peterdi, MD, PhD, professor of physiology and biophysics at the Keck School of Medicine.
From human behavior such as mother/infant bonding, addiction and communication disorders to devastating brain diseases like Parkinson’s and Alzheimer’s disease, neuroscientists and other researchers from FAU’s Brain Institute are at the forefront of innovative research that will generate knowledge to benefit society.
A study by Indiana University researchers has identified 24 compounds -- including caffeine -- with the potential to boost an enzyme in the brain shown to protect against dementia. The research appeared March 7 in the journal Scientific Reports.
Using red blood cells modified to carry disease-specific antigens, scientists from Whitehead Institute and Boston Children’s Hospital have prevented and alleviated two autoimmune diseases—multiple sclerosis (MS) and type 1 diabetes—in early stage mouse models.
A new study from researchers at the UAB shows that Parkinson’s disease, and medications to treat Parkinson’s, have distinct effects on the composition of the trillions of bacteria that make up the gut microbiome.
Clinicians and researchers from the GW Department of Dermatology will present on a variety of topics, including nanotechnology, fungal infections of the skin, cannabis for autoimmune diseases, contact dermatitis, and public health threats at the 75th Annual Meeting of the American Academy of Dermatology.
Study to look at role of the cytokine interleukin-10 (IL-10) in suppressing antibody production in certain autoimmune disorders.
A Mayo Clinic research team has found a new gene mutation that may be a risk factor for late-onset Alzheimer’s disease in African-Americans.
Scientists at Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified a new regulator of the innate immune response—the immediate, natural immune response to foreign invaders. The study, published recently in Nature Microbiology, suggests that therapeutics that modulate the regulator—an immune checkpoint—may represent the next generation of antiviral drugs, vaccine adjuvants, cancer immunotherapies, and treatments for autoimmune disease.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right